TORRENT PHARMA

📅 Teleconference Scheduled Torrent Pharmaceuticals has scheduled an investor & analyst call on June 30, 2025, to discuss the acquisition of JB Chemicals & Pharmaceuticals Ltd. 📞 Dial-in Details Provided Stakeholders are invited to join the session using the shared dial-in credentials to gain insights into the deal structure, strategic rationale, and future roadmap. 🤝 This move marks a significant expansion in Torrent Pharma's portfolio and market presence.